Cabaletta Bio Stock (NASDAQ: CABA) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 962.893K |
Day Range | - - - |
52 Wk Range | 7.690 - 26.350 |
Market Cap | $610.593M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 23 |
Short Interest | 18.21% |
Days to Cover | 7.25 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Cabaletta Bio (NASDAQ: CABA) through any online brokerage.
Other companies in Cabaletta Bio’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), Cogent Biosciences (NASDAQ:COGT), Korro Bio (NASDAQ:KRRO), Pharming (NASDAQ:PHAR) and Mesoblast (NASDAQ:MESO).
The latest price target for Cabaletta Bio (NASDAQ: CABA) was reported by Cantor Fitzgerald on Friday, April 5, 2024. The analyst firm set a price target for 50.00 expecting CABA to rise to within 12 months (a possible 295.10% upside). 22 analyst firms have reported ratings in the last year.
The stock price for Cabaletta Bio (NASDAQ: CABA) is $12.655 last updated April 24, 2024 at 6:45 PM EDT.
There are no upcoming dividends for Cabaletta Bio.
Cabaletta Bio’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Cabaletta Bio.
Cabaletta Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.